Show simple item record

dc.contributor.authorChamseddine, Ibrahim M.
dc.contributor.authorKokkolaras, Michael
dc.date.accessioned2022-02-04T22:11:14Z
dc.date.available2022-02-04T22:11:14Z
dc.date.copyright9/8/2020 12:00:00 AM
dc.date.issued2020
dc.identifier.issn0148-0731
dc.identifier.otherbio_143_01_011002.pdf
dc.identifier.urihttp://yetl.yabesh.ir/yetl1/handle/yetl/4275051
dc.description.abstractNanoparticle-mediated drug delivery may be a promising alternative to traditional chemotherapy of high systemic toxicity. Tumor tissue architecture poses a challenge to delivery of nanoparticles. Small and spherical nanoparticles have poor adherence to the tumor vasculature, while larger and more eccentric ones create high heterogeneity in tissue-to-drug exposure. In previous work, we quantified these tradeoffs using numerical optimization. In this study, we demonstrate that simultaneous delivery of multiple nanoparticle designs can enhance drug distribution in the cancerous tissue without compromising nanoparticle tumoral accumulation. We formulate and solve optimization problems to find the optimal constituent of the heterogeneous injection in terms of nanoparticle design diversity that increases drug distribution by 14%.
dc.publisherThe American Society of Mechanical Engineers (ASME)
dc.titleA Dual Nanoparticle Delivery Strategy for Enhancing Drug Distribution in Cancerous Tissue
dc.typeJournal Paper
dc.journal.volume142
dc.journal.issue12
dc.journal.titleJournal of Biomechanical Engineering
dc.identifier.doi10.1115/1.4047657
dc.journal.fristpage0124501-1
dc.journal.lastpage0124501-12
dc.page12
dc.treeJournal of Biomechanical Engineering:;2020:;volume( 142 ):;issue: 012
dc.contenttypeFulltext


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record